November 21, 2024
Warm Autoimmune Hemolytic Anemia Drug Pipeline Analysis
According to the National Organization for Rare Disorders, warm autoimmune hemolytic anaemia (wAIHA) is the most common subtype of autoimmune hemolytic anemia, affecting approximately 1 to 3 per 100,000 people every year. Warm Autoimmune Hemolytic Anemia Drug Pipeline Analysis The disease can occur at any age; therefore, there is a significant focus on designing effective…
Dhruv
0